SequelSEC

VIVOS INC RDGL

Surgical & Medical Instruments & Apparatus · CIK 0001449349 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$99.10K
Fiscal year ended 2026-06-30
Operating income
-$2.83M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$47.71MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.10Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue697.7×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity28.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Gross margin-87.4%1th
Current ratio14.00x98th
CapEx / revenue150.9%97th
Operating margin-4628.7%3th
Net margin-4483.9%4th
Revenue YoY growth144.3%96th
FCF margin-3160.2%7th
R&D / revenue515.1%91th

VIVOS INC (RDGL) reported revenue of $99.10K and net income of -$3.60M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from VIVOS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

VIVOS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$99.10K
Cost of revenue$124.76K
Gross profit-$25.66K
Operating income-$2.83M
Net income-$3.60M
Research & development$212.09K
Weighted-average diluted sharesUnavailable
Pretax income-$3.60M
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$304.40K
Selling & marketingUnavailable

Balance

VIVOS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$2.88M
Current assets$2.44M
Total liabilities$123.96K
Current liabilities$49.97K
Total equity incl. NCI$2.76M
Temporary (mezzanine) equityUnavailable
Inventory$56.43K
Accounts receivable$15.65K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

VIVOS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$2.17M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$2.19M
Net change in cash-$324.57K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

VIVOS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin-25.9%
Operating margin-2852.5%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio48.85x
Revenue YoY growth91.5%
Net margin-3633.6%
R&D / revenue214.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RDGL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.